Adeno-associated viruses containing bFGF or BDNF are neuroprotective against excitotoxicity

Current Eye Research

Volumn 29, Issue 6, 2004, Pages 379-386

  Schuettauf, Frank ^a,d   Vorwerk, Christian ^a   Naskar, Rita ^a   Orlin, Anton ^a   Quinto, Kristine ^a   Zurakowski, David ^b   Dejneka, Nadine S ^a   Klein, Ronald L ^c   Meyer, Edward M ^c   Bennett, Jean ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Adeno associated virus; Basic fibroblast growth factor; Brain derived neurotrophic factor; Excitotoxicity; Retinal ganglion cells

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; GREEN FLUORESCENT PROTEIN; N METHYL DEXTRO ASPARTIC ACID; NEUROPROTECTIVE AGENT; PARVOVIRUS VECTOR; RECOMBINANT DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; EXCITOTOXICITY; GENE TARGETING; HUMAN; HUMAN CELL; NEUROPROTECTION; NONHUMAN; OPTIC NERVE INJURY; PRIORITY JOURNAL; RAT; RETINA GANGLION CELL;

ANIMALS; APOPTOSIS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL SURVIVAL; CYTOPROTECTION; DEPENDOVIRUS; EXCITATORY AMINO ACID AGONISTS; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION; GENE THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; N-METHYLASPARTATE; NERVE CRUSH; NEUROPROTECTIVE AGENTS; OPTIC NERVE; RATS; RATS, SPRAGUE-DAWLEY; RETINAL DISEASES; RETINAL GANGLION CELLS; TRANSFECTION;

EID: 19944431910     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1080/02713680490517872     Document Type: Article

References (45)

1. Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1988;1:623-634.
2. 2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons. J Neurochem. 1995;65:1740-1751.
3. Mansour-Robaey S, Clarke DB, Wang YC, Bray GM, Aguayo AJ. Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells. Proc Natl Acad Sci U S A. 1994;91:1632-1636.
4. Peinado-Ramon P, Salvador M, Villegas-Perez MP, Vidal Sanz M. Effects of axotomy and intraocular administration of NT-4, NT-3, and brain-derived neurotrophic factor on the survival of adult rat retinal ganglion cells. A quantitative in vivo study. Invest Ophthalmol Vis Sci. 1996;37:489-500.
5. Watanabe M, Sawai H, Fukuda Y. Survival of axotomized retinal ganglion cells in adult mammals. Clin Neurosci. 1997;4:233-239.
6. Rocha M, Martins RA, Linden R. Activation of NMDA receptors protects against glutamate neurotoxicity in the retina: Evidence for the involvement of neurotrophins. Brain Res. 1999;827:79-92.
7. Unoki K, LaVail MM. Protection of the rat retina from ischemic injury by brain-derived neurotrophic factor, ciliary neurotrophic factor, and basic fibroblast growth factor. Invest Ophthalmol Vis Sci. 1994;35:907-915.
8. Akimoto M, Miyatake S, Kogishi J, Hangai M, Okazaki K, Takahashi JC, Saiki M, Iwaki M, Honda Y. Adenovirally expressed basic fibroblast growth factor rescues photoreceptor cells in RCS rats. Invest Ophthalmol Vis Sci. 1999;40:273-279.
9. Uteza Y, Rouillot JS, Kobetz A, Marchant D, Pecqueur S, Arnaud E, Prats H, Honiger J, Dufier JL, Abitbol M, Neuner-Jehle M. Intravitreous transplantation of encapsulated fibroblasts secreting the human fibroblast growth factor 2 delays photoreceptor cell degeneration in Royal College of Surgeons rats. Proc Natl Acad Sci U S A. 1999;96:3126-3131.
10. Lau D, McGee LH, Zhou S, Rendahl KG, Manning WC, Escobedo JA, Flannery JG. Retinal degeneration is slowed in transgenic rats by AAV-mediated delivery of FGF-2. Invest Ophthalmol Vis Sci. 2000;41:3622-3633.
11. Zhang C, Takahashi K, Lam TT, Tso MO. Effects of basic fibroblast growth factor in retinal ischemia. Invest Ophthalmol Vis Sci. 1994;35:3163-3168.
12. Dreyfus H, Sahel J, Heidinger V, Mohand-Said S, Guerold B, Meuillet E, Fontaine V, Hicks D. Gangliosides and neurotrophic growth factors in the retina. Molecular interactions and applications as neuroprotective agents. Ann N Y Acad Sci. 1998;845:240-252.
13. Monahan PE, Samulski RJ. Adeno-associated virus vectors for gene therapy: More pros than cons? Mol Med Today. 2000;6:433-440.
14. Martin KR, Quigley HA, Zack DJ, Levkovitch-Verbin H, Kielczewski J, Valenta D, Baumrind L, Pease ME, Klein RL, Hauswirth WW. Gene therapy with brainderived neurotrophic factor as a protection: Retinal ganglion cells in a rat glaucoma model. Invest Ophthalmol Vis Sci. 2003;44:4357-4365.
15. Cheng L, Sapieha P, Kittlerova P, Hauswirth WW, Di Polo A. TrkB gene transfer protects retinal ganglion cells from axotomy-induced death in vivo. J Neurosci. 2002;22:3977-3986.
16. Yoles E, Muller S, Schwartz M. NMDA-receptor antagonist protects neurons from secondary degeneration after partial optic nerve crush. J Neurotrauma. 1997;14:665-675.
17. Yoles E, Schwartz M. Elevation of intraocular glutamate levels in rats with partial lesion of the optic nerve. Arch Ophthalmol. 1998;116:906-910.
18. Zolotukhin S, Byrne BJ, Mason E, Zolotukhin I, Potter M, Chesnut K, Summerford C, Samulski RJ, Muzyczka N. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther. 1999;6:973-985.
19. Grimm D, Kern A, Rittner K, Kleinschmidt JA. Novel tools for production and purification of recombinant adenoassociated virus vectors. Hum Gene Ther. 1998;9:2745-2760.
20. Liang FQ, Dejneka NS, Cohen DR, Krasnoperova NV, Lem J, Maguire AM, Dudus L, Fisher KJ, Bennett J. AAV-mediated delivery of ciliary neurotrophic factor prolongs photoreceptor survival in the rhodopsin knockout mouse. Mol Ther. 2001;3:241-248.
21. Vorwerk CK, Lipton SA, Zurakowski D, Hyman BT, Sabel BA, Dreyer EB. Chronic low-dose glutamate is toxic to retinal ganglion cells toxicity blocked by memantine. Invest Ophthalmol Vis Sci. 1996;37:1618-1624.
22. Naskar R, Vorwerk CK, Dreyer EB. Concurrent down-regulation of a glutamate transporter and receptor in glaucoma. Invest Ophthalmol Vis Sci. 2000;41:1940-1944.
23. Dreyer EB, Vorwerk CK, Zurakowski D, Simon PD, Bennett J. Infection with adeno-associated virus may protect against excitotoxicity. Neuroreport. 1999;10:2887-2890.
24. Bahr M, Vanselow J, Thanos S. Ability of adult rat ganglion cells to regrow axons in vitro can be influenced by fibroblast growth factor and gangliosides. Neurosci Lett. 1989;96:197-201.
25. Cui Q, Harvey AR. At least two mechanisms are involved in the death of retinal ganglion cells following target ablation in neonatal rats. J Neurosci. 1995;15:8143-8155.
26. Germani E, Lesma E, Di Giulio AM, Gorio A. Progressive and selective changes in neurotrophic factor expression and substance p axonal transport induced by perinatal diabetes: Protective action of antioxidant treatment. J Neurosci Res. 1999;57:521-528.
27. Blanquet PR, Jonet L. Signal-regulated proteins and fibroblast growth factor receptors: Comparative immunolocalization in rat retina. Neurosci Lett. 1996;214:135-138.
28. Guillonneau X, Regnier-Ricard F, Laplace O, Jonet L, Bryckaert M, Courtois Y, Mascarelli F. Fibroblast growth factor (FGF) soluble receptor 1 acts as a natural inhibitor of FGF2 neurotrophic activity during retinal degeneration. Mol Biol Cell. 1998;9:2785-2802.
29. Tcheng M, Fuhrmann G, Hartmann MP, Courtois Y, Jeanny JC. Spatial and temporal expression patterns of FGF receptor genes type 1 and type 2 in the developing chick retina. Exp Eye Res. 1994;58:351-358.
30. Ohuchi H, Koyama E, Myokai F, Nohno T, Shiraga F, Matsuo T, Matsuo N, Taniguchi S, Noji S. Expression patterns of two fibroblast growth factor receptor genes during early chick eye development. Exp Eye Res. 1994;58:649-658.
31. Ornitz DM, Xu J, Colvin JS, McEwen DG, MacArthur CA, Coulier F, Gao G, Goldfarb M. Receptor specificity of the fibroblast growth factor family. J Biol Chem. 1996;271:15292-15297.
32. DiStefano PS, Friedman B, Radziejewski C, Alexander C, Boland P, Schick CM, Lindsay RM, Wiegand SJ. The neurotrophins BDNF, NT-3, and NGF display distinct patterns of retrograde axonal transport in peripheral and central neurons. Neuron. 1992;8:983-993.
33. von Bartheld CS, Williams R, Lefcort F, Clary DO, Reichardt LF, Bothwell M. Retrograde transport of neurotrophins from the eye to the brain in chick embryos: Roles of the p75NTR and trkB receptors. J Neurosci. 1996;16:2995-3008.
34. Klocker N, Kermer P, Weishaupt JH, Labes M, Ankerhold R, Bahr M. Brain-derived neurotrophic factor-mediated neuroprotection of adult rat retinal ganglion cells in vivo does not exclusively depend on phosphatidylinositol- 3′-kinase/protein kinase B signaling. J Neurosci. 2000;20:6962-6967.
35. Nakazawa T, Tamai M, Mori N. Brain-derived neurotrophic factor prevents axotomized retinal ganglion cell death through MAPK and PI3K signaling pathways. Invest Ophthalmol Vis Sci. 2002;43:3319-3326.
36. Vecino E, Caminos E, Ugarte M, Martin-Zanca D, Osborne NN. Immunohistochemical distribution of neurotrophins and their receptors in the rat retina and the effects of ischemia and reperfusion. Gen Pharmacol. 1998;30:305-314.
37. Dudus L, Anand V, Acland GM, Chen SJ, Wilson JM, Fisher KJ, Maguire AM, Bennett J. Persistent transgene product in retina, optic nerve and brain after intraocular injection of rAAV. Vision Res. 1999;39:2545-2553.
38. Bennett J, Anand V, Acland GM, Maguire AM. Cross-species comparison of in vivo reporter gene expression after recombinant adeno-associated virus-mediated retinal transduction. Methods Enzymol. 2000;316:777-789.
39. Nesbit M, Nesbit HK, Bennett J, Andl T, Hsu MY, Dejesus E, McBrian M, Gupta AR, Eck SL, Herlyn M. Basic fibroblast growth factor induces a transformed phenotype in normal human melanocytes. Oncogene. 1999;18:6469-6476.
40. Di Polo A, Aigner LJ, Dunn RJ, Bray GM, Aguayo AJ. Prolonged delivery of brain-derived neurotrophic factor by adenovirus-infected Muller cells temporarily rescues injured retinal ganglion cells. Proc Natl Acad Sci U S A. 1998;95:3978-3983.
41. Bennett J, Wilson J, Sun D, Forbes B, Maguire A. Adenovirus vector-mediated in vivo gene transfer into adult murine retina. Invest Ophthalmol Vis Sci. 1994;35:2535-2542.
42. Li T, Adamian M, Roof DJ, Berson EL, Dryja TP, Roessler BJ, Davidson BL. In vivo transfer of a reporter gene to the retina mediated by an adenoviral vector. Invest Ophthalmol Vis Sci. 1994;35:2543-2549.
43. Liang FQ, Surace E, Dejneka NS, Maguire AM, Bennett J. 2003. Muller cell transduction by AAV2 in normal and degenerative retinas. In: LaVail mM, Hollyfield JG, Anderson RE, eds. Retinal Degenerations Mechanisms and Experimental Therapy. New York: Kluwer Academic/Plenum Publishers 2003;439-445.
44. Hoffman LM, Maguire AM, Bennett J. Cell-mediated immune response and stability of intraocular transgene expression after adenovirus-mediated delivery. Invest Ophthalmol Vis Sci. 1997;38:2224-2233.
45. Bennett J, Maguire AM, Cideciyan AV, Schnell M, Glover E, Anand V, Aleman TS, Chirmule N, Gupta AR, Huang Y, Gao GP, Nyberg WC, Tazelaar J, Hughes J, Wilson JM, Jacobson SG. Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina. Proc Natl Acad Sci U S A. 1999;96:9920-9925.